Source: Eur Respir J 2012; 39: 7-8
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Waterer G.W., Lopez D.. Improving outcomes from community-acquired pneumonia: we need to be more sophisticated about cause and effect. Eur Respir J 2012; 39: 7-8

Member's Comments

No comment yet.

Related content which might interest you: Prevention is better than cure: time to change the focus of community-acquired pneumonia management Source: Eur Respir J 2015; 45: 1524-1525 Year: 2015 Potential impact and relevance of diagnostics in the management of respiratory tract infections: from COVID to hospital-acquired pneumonia Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 991-992 Year: 2011 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 992-993 Year: 2011 Management of community-acquired pneumonia: new evidence-based algorithms. Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 The impact of a stewardship programme on outcomes in patients admitted with community-acquired pneumonia Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections Year: 2020 Implementation of evidence based strategies for prevention of ventilator-associated pneumonia Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008 Comparison of the predictive performance of severity assessment tools in community-acquired or health care-associated pneumonia Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Treatment failure of community-acquired pneumonia: risk factors and consequences Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections Year: 2012 The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis Source: Eur Respir J 2012; 39: 611-618 Year: 2012 Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals Source: Eur Respir J 2005; 26: Suppl. 49, 638s Year: 2005 A local perspective on risk factors and short term outcomes in community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2011; 39: 156-162 Year: 2012 Initial management of pneumonia and sepsis: factors associated with improved outcome Source: Eur Respir J 2012; 39: 156-162 Year: 2012 COPD: what is the frequency and impact of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Validation of a predictive rule for the management of community-acquired pneumonia Source: Eur Respir J 2006; 27: 151-157 Year: 2006 Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality Source: Eur Respir J 2011; 38: 253-260 Year: 2011